Avego Management, LLC

Avego Management, LLC is a multi-strategy healthcare-focused investment firm based in the United States. The firm operates through three distinct strategies: Avego Healthcare Capital, Avego BioScience Capital, and Velan Capital. Avego Healthcare Capital provides growth capital to revenue-generating businesses and partners with entrepreneurs to build new companies. Avego BioScience Capital focuses on mid-to-late stage venture financings for life sciences companies. Velan Capital invests in publicly traded companies in the healthcare sector, focusing on undervalued assets and high-quality management teams.

The firm's investment approach is driven by scientific and operating experience, aiming to invest in private and public companies developing and commercializing innovative products and services for patients, practitioners, and other stakeholders across the healthcare continuum. Avego's values include operating with integrity, aligning on success, persevering to overcome challenges, leading with science, and focusing on growth. These principles guide their investment philosophy and decision-making processes.

Avego's portfolio includes investments in companies such as Aro Biotherapeutics, Ensho Therapeutics, CellCentric, and MapLight Therapeutics. The firm has also been involved in significant financing rounds, including a $22 million investment in PBS Biotech and a $40 million financing commitment to AtomVie Global Radiopharma Inc. These investments reflect Avego's commitment to supporting innovative healthcare companies and advancing patient care through strategic partnerships and capital infusion.